BAT: invests in cannabis specialist Sanity group
(CercleFinance.com) - Yesterday BAT announced that it is taking a minority and non-majority stake in Sanity Group, a Berlin-based group with an established product portfolio of CBD and medical cannabis brands.
In addition, Sanity Group also has a proven track record in researching, developing and marketing cannabis products, BAT said.
Kingsley Wheaton, BAT's director of growth, said the investment reflects BAT's desire to expand into many areas beyond nicotine as part of its "A Better Tomorrow" program.
Last March, BAT announced a "strategic collaboration" in R&D with Canadian Organigram Holdings Inc, a licensed producer of cannabis products and extracts.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
In addition, Sanity Group also has a proven track record in researching, developing and marketing cannabis products, BAT said.
Kingsley Wheaton, BAT's director of growth, said the investment reflects BAT's desire to expand into many areas beyond nicotine as part of its "A Better Tomorrow" program.
Last March, BAT announced a "strategic collaboration" in R&D with Canadian Organigram Holdings Inc, a licensed producer of cannabis products and extracts.
Copyright (c) 2022 CercleFinance.com. All rights reserved.